368 related articles for article (PubMed ID: 10933050)
1. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.
Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG
Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
3. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.
Steffens S; Frank S; Fischer U; Heuser C; Meyer KL; Dobberstein KU; Rainov NG; Kramm CM
Cancer Gene Ther; 2000 May; 7(5):806-12. PubMed ID: 10830728
[TBL] [Abstract][Full Text] [Related]
4. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
5. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
Tjuvajev JG; Avril N; Oku T; Sasajima T; Miyagawa T; Joshi R; Safer M; Beattie B; DiResta G; Daghighian F; Augensen F; Koutcher J; Zweit J; Humm J; Larson SM; Finn R; Blasberg R
Cancer Res; 1998 Oct; 58(19):4333-41. PubMed ID: 9766661
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy.
Tjuvajev JG; Finn R; Watanabe K; Joshi R; Oku T; Kennedy J; Beattie B; Koutcher J; Larson S; Blasberg RG
Cancer Res; 1996 Sep; 56(18):4087-95. PubMed ID: 8797571
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.
Blasberg RG; Tjuvajev JG
Q J Nucl Med; 1999 Jun; 43(2):163-9. PubMed ID: 10429512
[TBL] [Abstract][Full Text] [Related]
9. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.
Ponomarev V; Doubrovin M; Lyddane C; Beresten T; Balatoni J; Bornman W; Finn R; Akhurst T; Larson S; Blasberg R; Sadelain M; Tjuvajev JG
Neoplasia; 2001; 3(6):480-8. PubMed ID: 11774030
[TBL] [Abstract][Full Text] [Related]
10. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
11. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
12. Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET.
Hackman T; Doubrovin M; Balatoni J; Beresten T; Ponomarev V; Beattie B; Finn R; Bornmann W; Blasberg R; Tjuvajev JG
Mol Imaging; 2002; 1(1):36-42. PubMed ID: 12920859
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression.
Brust P; Haubner R; Friedrich A; Scheunemann M; Anton M; Koufaki ON; Hauses M; Noll S; Noll B; Haberkorn U; Schackert G; Schackert HK; Avril N; Johannsen B
Eur J Nucl Med; 2001 Jun; 28(6):721-9. PubMed ID: 11440032
[TBL] [Abstract][Full Text] [Related]
14. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging.
Ponomarev V; Doubrovin M; Serganova I; Vider J; Shavrin A; Beresten T; Ivanova A; Ageyeva L; Tourkova V; Balatoni J; Bornmann W; Blasberg R; Gelovani Tjuvajev J
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):740-51. PubMed ID: 15014901
[TBL] [Abstract][Full Text] [Related]
15. PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene.
Miyagawa M; Anton M; Haubner R; Simoes MV; Städele C; Erhardt W; Reder S; Lehner T; Wagner B; Noll S; Noll B; Grote M; Gambhir SS; Gansbacher B; Schwaiger M; Bengel FM
J Nucl Med; 2004 Nov; 45(11):1917-23. PubMed ID: 15534063
[TBL] [Abstract][Full Text] [Related]
16. Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice.
Hsieh CH; Kuo JW; Lee YJ; Chang CW; Gelovani JG; Liu RS
J Nucl Med; 2009 Dec; 50(12):2049-57. PubMed ID: 19910419
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir.
Deng WP; Yang WK; Lai WF; Liu RS; Hwang JJ; Yang DM; Fu YK; Wang HE
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):99-109. PubMed ID: 14513292
[TBL] [Abstract][Full Text] [Related]
18. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.
Likar Y; Dobrenkov K; Olszewska M; Vider E; Shenker L; Cai S; Pillarsetty N; Hricak H; Ponomarev V
J Nucl Med; 2008 May; 49(5):713-20. PubMed ID: 18413388
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Uch R; Gérolami R; Faivre J; Hardwigsen J; Mathieu S; Mannoni P; Bagnis C
Cancer Gene Ther; 2003 Sep; 10(9):689-95. PubMed ID: 12944988
[TBL] [Abstract][Full Text] [Related]
20. Quantitative kinetics of [124I]FIAU in cat and man.
Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
